Cetera Investment Advisers’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Buy |
36,017
+1,387
| +4% | +$122K | 0.01% | 1506 |
|
|
2025
Q1 | $3.16M | Sell |
34,630
-3,166
| -8% | -$289K | 0.01% | 1406 |
|
|
2024
Q4 | $3.26M | Buy |
37,796
+983
| +3% | +$84.8K | 0.01% | 1301 |
|
|
2024
Q3 | $3.5M | Buy |
36,813
+7,365
| +25% | +$700K | 0.01% | 1216 |
|
|
2024
Q2 | $2.69M | Buy |
29,448
+3,237
| +12% | +$296K | 0.01% | 1361 |
|
|
2024
Q1 | $2.38M | Buy |
26,211
+19,912
| +316% | +$1.81M | 0.01% | 1429 |
|
|
2023
Q4 | $513K | Buy |
6,299
+761
| +14% | +$61.9K | ﹤0.01% | 1473 |
|
|
2023
Q3 | $442K | Buy |
5,538
+1,255
| +29% | +$100K | ﹤0.01% | 1488 |
|
|
2023
Q2 | $337K | Buy |
4,283
+109
| +3% | +$8.59K | ﹤0.01% | 1667 |
|
|
2023
Q1 | $324K | Buy |
4,174
+1,253
| +43% | +$97.3K | ﹤0.01% | 1657 |
|
|
2022
Q4 | $227K | Buy |
+2,921
| New | +$227K | ﹤0.01% | 1831 |
|
|
2022
Q3 | – | Sell |
-3,014
| Closed | -$232K | – | 1838 |
|
|
2022
Q2 | $232K | Buy |
3,014
+206
| +7% | +$15.9K | ﹤0.01% | 1583 |
|
|
2022
Q1 | $224K | Buy |
2,808
+150
| +6% | +$12K | ﹤0.01% | 1646 |
|
|
2021
Q4 | $205K | Buy |
+2,658
| New | +$205K | ﹤0.01% | 1725 |
|